Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26724 | 203 | 38.4 | 80% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VIROSOMES | Author keyword | 12 | 36% | 13% | 27 |
| 2 | FUSOGENIC LIPOSOME | Author keyword | 10 | 52% | 7% | 14 |
| 3 | VIROSOME | Author keyword | 9 | 36% | 10% | 20 |
| 4 | HVJ E | Author keyword | 5 | 60% | 3% | 6 |
| 5 | GENE THER Y SCI | Address | 5 | 12% | 21% | 42 |
| 6 | HVJ | Author keyword | 4 | 47% | 3% | 7 |
| 7 | INACTIVATED SENDAI VIRUS HVJ E | Author keyword | 3 | 100% | 1% | 3 |
| 8 | SENDAI VIRUS STRAIN TIANJIN | Author keyword | 3 | 100% | 1% | 3 |
| 9 | INFLUENZA VIROSOMES | Author keyword | 3 | 50% | 2% | 4 |
| 10 | HEMAGGLUTINATING VIRUS OF JAPAN ENVELOPE | Author keyword | 3 | 60% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VIROSOMES | 12 | 36% | 13% | 27 | Search VIROSOMES | Search VIROSOMES |
| 2 | FUSOGENIC LIPOSOME | 10 | 52% | 7% | 14 | Search FUSOGENIC+LIPOSOME | Search FUSOGENIC+LIPOSOME |
| 3 | VIROSOME | 9 | 36% | 10% | 20 | Search VIROSOME | Search VIROSOME |
| 4 | HVJ E | 5 | 60% | 3% | 6 | Search HVJ+E | Search HVJ+E |
| 5 | HVJ | 4 | 47% | 3% | 7 | Search HVJ | Search HVJ |
| 6 | INACTIVATED SENDAI VIRUS HVJ E | 3 | 100% | 1% | 3 | Search INACTIVATED+SENDAI+VIRUS+HVJ+E | Search INACTIVATED+SENDAI+VIRUS+HVJ+E |
| 7 | SENDAI VIRUS STRAIN TIANJIN | 3 | 100% | 1% | 3 | Search SENDAI+VIRUS+STRAIN+TIANJIN | Search SENDAI+VIRUS+STRAIN+TIANJIN |
| 8 | INFLUENZA VIROSOMES | 3 | 50% | 2% | 4 | Search INFLUENZA+VIROSOMES | Search INFLUENZA+VIROSOMES |
| 9 | HEMAGGLUTINATING VIRUS OF JAPAN ENVELOPE | 3 | 60% | 1% | 3 | Search HEMAGGLUTINATING+VIRUS+OF+JAPAN+ENVELOPE | Search HEMAGGLUTINATING+VIRUS+OF+JAPAN+ENVELOPE |
| 10 | HEPATITIS C VACCINE | 2 | 67% | 1% | 2 | Search HEPATITIS+C+VACCINE | Search HEPATITIS+C+VACCINE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INFLUENZA VIRUS ENVELOPES | 13 | 67% | 6% | 12 |
| 2 | HVJ ENVELOPE VECTOR | 8 | 41% | 8% | 16 |
| 3 | SENDAI VIRAL ENVELOPES | 5 | 63% | 2% | 5 |
| 4 | VIRUS ENVELOPES VIROSOMES | 3 | 100% | 1% | 3 |
| 5 | HEMAGGLUTINATING VIRUS | 3 | 19% | 6% | 13 |
| 6 | INFLUENZA VIROSOMES | 3 | 35% | 3% | 6 |
| 7 | VIRUS ENVELOPES | 3 | 30% | 3% | 7 |
| 8 | ANTIGEN EPITOPE GP100280 288 | 2 | 67% | 1% | 2 |
| 9 | RECONSTITUTED INFLUENZA VIROSOMES | 2 | 40% | 2% | 4 |
| 10 | FUSOGENIC LIPOSOMES | 2 | 21% | 3% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Influenza virosomes as vaccine adjuvant and carrier system | 2013 | 12 | 73 | 42% |
| Influenza virosomes as a vaccine adjuvant and carrier system | 2011 | 27 | 82 | 30% |
| Influenza vaccines: The virosome concept | 2009 | 26 | 7 | 43% |
| Virus-like particles - universal molecular toolboxes | 2007 | 102 | 53 | 17% |
| Virosomes for antigen and DNA delivery | 2005 | 45 | 51 | 43% |
| Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations | 2007 | 25 | 65 | 45% |
| Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs | 2004 | 142 | 79 | 20% |
| Applications of influenza virosomes as a delivery system | 2006 | 15 | 57 | 51% |
| Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application | 2013 | 3 | 25 | 36% |
| Virosome: A novel vector to enable multi-modal strategies for cancer therapy | 2012 | 10 | 100 | 26% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GENE THER Y SCI | 5 | 12% | 21% | 42 |
| 2 | CANC SCI MP824 | 1 | 50% | 0.5% | 1 |
| 3 | G SEGRE PHARMACOL | 1 | 50% | 0.5% | 1 |
| 4 | HI TECH IND ESTATE | 1 | 50% | 0.5% | 1 |
| 5 | HOSP P INFECT | 1 | 50% | 0.5% | 1 |
| 6 | TUMOUR VIROL GRP | 1 | 50% | 0.5% | 1 |
| 7 | MOL IMMUNOLSTATE GENET ENGN | 0 | 33% | 0.5% | 1 |
| 8 | CELL THER EUT | 0 | 17% | 1.0% | 2 |
| 9 | MED MICROBIOL RETROSCREEN VIROL | 0 | 25% | 0.5% | 1 |
| 10 | OSPED CIVICO | 0 | 25% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000207307 | FUSION PEPTIDE//MEMBRANE FUSION//VIRAL FUSION PEPTIDE |
| 2 | 0.0000138269 | FUSOGENIC LIPIDS//DRUG DELIVERY SYST DEV//B30 MDP |
| 3 | 0.0000120026 | VACCINE DELIVERY//PLG MICROPARTICLES//ADJUVANT UNIT |
| 4 | 0.0000096285 | HEMAGGLUTINATING VIRUS OF JAPAN//GAX//HVJ LIPOSOME |
| 5 | 0.0000088111 | TUMOR GRAFT//MACROTRANSFECTION//MINITRANSFECTION |
| 6 | 0.0000088063 | ENGN CHEM KANAGAWA KU//PHOSPHOLIPID OLEIC ACID MONOLAYERS//POLYETHYLENE OXIDE LIPID |
| 7 | 0.0000077372 | V PROTEIN//SENDAI VIRUS//PARAMYXOVIRUS |
| 8 | 0.0000076390 | AS03//UNIVERSAL VACCINE//HETEROSUBTYPIC IMMUNITY |
| 9 | 0.0000069417 | CATIONIC LIPID//CATIONIC LIPIDS//CATIONIC LIPOSOME |
| 10 | 0.0000059298 | VIRAL ONCOLYSATE//CELLULAR IMMUNOL D010//MTH 68 H |